Integrating IL-12 into therapeutic cancer vaccines.
Gajewski
Thomas F
TF
Departments of Pathology and Medicine, Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Ave., MC2115, Chicago, IL 60637, USA. tgajewsk@medicine.bsd.uchicago.edu
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology*; D008213:Lymphocyte Activation; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D019496:Cancer Vaccines; D018664:Interleukin-12